Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-097-4 | CAS number: 37353-75-6 1 - 4.5 moles propoxylated
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: Expert assessment
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Estimation based on testing performed on this class of substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
- Objective of study:
- other: ADME assessment
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Assessment based on data presented in registration dossier. No further animal testing is justified
- GLP compliance:
- no
Test material
- Reference substance name:
- 4,4'-Isopropylidenediphenol, propoxylated
- EC Number:
- 500-097-4
- EC Name:
- 4,4'-Isopropylidenediphenol, propoxylated
- Cas Number:
- 37353-75-6
- Molecular formula:
- The substance is a UVCB and contains a series of homologues that have the general molecular formula C15H16O2.(C3H6O)n, where 2 ≤ n ≤ 10 (average degree of propoxylation: => 1 ; < 4.5 )
- IUPAC Name:
- 4,4-'isopropylidene, propoxylated (1 - 4.5 moles propoxylated)
Constituent 1
- Radiolabelling:
- no
Results and discussion
Main ADME resultsopen allclose all
- Type:
- absorption
- Type:
- distribution
- Type:
- metabolism
- Type:
- excretion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption by oral route as transient systemic effects seen in test animals
- Details on distribution in tissues:
- Effects indicate exposure to liver and kidneys
- Details on excretion:
- No firm evidence, but kidney response seen in highest treatment group
Metabolite characterisation studies
- Metabolites identified:
- no
Any other information on results incl. tables
Substance is known to be readily biodegradable, suggesting that metabolism to CO2 will occur in biological systems
Applicant's summary and conclusion
- Conclusions:
- There appears to be limited risk of bioaccumulation
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
